ICD-10 Code D47.Z2 | Castleman disease Symptoms, Diagnosis, Billing

Castleman disease is a rare lymphoproliferative disorder characterized by the abnormal growth of lymphoid tissue. It can present as unicentric or multicentric forms, with clinical manifestations ranging from localized lymphadenopathy to systemic symptoms such as fever and weight loss. Accurate coding with ICD-10 Code D47.Z2 is essential for proper diagnosis, documentation, medical billing, and public health reporting, ensuring that healthcare providers can effectively manage and treat this complex condition.

What is ICD-10 Code D47.Z2 for Castleman disease?

ICD-10 Code D47.Z2 represents Castleman disease, a condition involving hyperplastic lymphoid tissue that can lead to significant morbidity. This code should be used when documenting cases of Castleman disease, particularly when distinguishing between unicentric and multicentric forms, to ensure accurate billing and clinical management.

ICD-10 Code D47.Z2 – Clinical Definition and Explanation of Castleman disease

Castleman disease is caused by an abnormal proliferation of lymphoid tissue, often linked to viral infections such as HHV-8. The condition can progress rapidly and may lead to severe complications, necessitating prompt medical attention.

Key Clinical Features:

• Lymphadenopathy, often localized or generalized.
• Systemic symptoms including fever, night sweats, and weight loss.
• Potential association with other malignancies or infections.
• Laboratory findings may include elevated inflammatory markers.

ICD-10 Code D47.Z2 for Castleman disease – SOAP Notes & Clinical Use

ICD-10 Code D47.Z2 is utilized in SOAP notes to document the clinical presentation, assessment, and treatment of Castleman disease. It plays a crucial role in both acute and chronic care settings, ensuring comprehensive patient management.

What Does ICD-10 Code D47.Z2 for Castleman disease Mean in SOAP Notes?

In SOAP notes, ICD-10 Code D47.Z2 connects subjective patient-reported symptoms and objective clinical findings to a formal diagnosis of Castleman disease. This code is vital for ensuring continuity of care, supporting accurate billing, and meeting EHR documentation standards.

Treatment Options for ICD-10 Code D47.Z2 – Castleman disease

Management of Castleman disease may require hospitalization, especially in severe cases. Treatment approaches vary based on the disease's form and severity.

Antibiotic Therapy:

• Not applicable as Castleman disease is not primarily infectious; however, secondary infections may require antibiotics.
• Consideration for prophylactic antibiotics in immunocompromised patients.

Supportive Care:

• Symptomatic treatment for fever and pain management.
• Monitoring for complications such as infections or organ dysfunction.
• Nutritional support and hydration.

Infection Control:

• Standard precautions to prevent infection spread.
• Isolation protocols if secondary infections are present.

How to Document Symptoms of Castleman disease (ICD-10 D47.Z2) in SOAP Notes

Subjective:

• Patient reports persistent fever and night sweats.
• History of unexplained weight loss over the past month.
• Complaints of fatigue and generalized malaise.
• Notable lymphadenopathy in the cervical region.

Objective:

• Physical examination reveals enlarged lymph nodes in multiple regions.
• Vital signs: temperature 101°F, heart rate 90 bpm.
• Laboratory tests show elevated C-reactive protein (CRP) and lymphocytosis.
• Imaging studies indicate lymphadenopathy in the mediastinum.

Secure, compliant, and built for trust

HIPAA-compliant and designed with privacy in mind, your patient’s data is protected. Focus on care while we safeguard your information.

Learn more

SOAP Note Guidelines for Diagnosing Castleman disease (ICD-10 Code D47.Z2)

Assessment:

• Diagnosis: Castleman disease, multicentric form, moderate severity.
• ICD-10 Code: D47.Z2.
• Triggers: Possible viral infection (HHV-8) and immune dysregulation.
• Consideration of differential diagnoses including lymphoma.

Plan:

• Initiate corticosteroid therapy to reduce lymphoid tissue hyperplasia.
• Monitor laboratory parameters and clinical symptoms closely.
• Educate the patient on signs of complications and when to seek care.
• Schedule follow-up in 2 weeks for reassessment.

Treatment & Plan Section for ICD-10 Code D47.Z2 – Castleman disease

• Corticosteroids as first-line treatment to manage symptoms.
• Consideration of immunotherapy or chemotherapy for severe cases.
• Patient education on disease process and management strategies.
• Regular follow-up appointments to monitor disease progression.

Using ICD-10 Code D47.Z2 for Castleman disease in Billing & SOAP Note Compliance

• Ensure accurate documentation of symptoms and clinical findings under Subjective (S) and Objective (O).
• Use D47.Z2 for billing related to Castleman disease management and treatment.
• Align treatment plans with clinical guidelines to support justified billing.
• Document any comorbidities or complications to enhance coding accuracy.

Related ICD-10 Codes Often Used with Castleman disease

• D47.Z1 – Other specified neoplasms of lymphoid, hematopoietic, and related tissue
• D47.0 – Lymphoproliferative disorders

ICD-10 Code D47.Z2 in Medical Billing and Insurance for Castleman disease

ICD-10 Code D47.Z2 is essential for accurate billing in hospital, ER, or infectious disease care settings.

Billing Notes:

• Document all relevant clinical findings and treatment plans to support the ICD-10 claim.
• Use D47.Z2 in conjunction with other codes for comprehensive billing.
• Ensure that documentation reflects the severity and complexity of the condition.
• Review payer-specific guidelines for coding and billing compliance.

Common CPT Pairings: